LaQuisaChimereHillMD

PubMed

• 1 citations
  Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas.
  LaQuisa C Hill, Rayne H Rouce, Mengfen J Wu, Tao Wang, Royce Ma, Huimin Zhang, Birju Mehta, Natalia Lapteva, Zhuyong Mei, Tyler S Smith, Lina Yang, Madhuwanti Srinivas...> ;Blood. 2024 Mar 28
• Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia.
  Wingchi K Leung, Alejandro G Torres Chavez, Matthew French-Kim, Paul Shafer, Maksim Mamonkin, LaQuisa C Hill, Manik Kuvalekar, Yovana Velazquez, Ayumi Watanabe, Norihi...> ;Blood. 2024 Jan 19
• Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas.
  Ibrahim N Muhsen, LaQuisa C Hill, Carlos A Ramos> ;Hematology/oncology Clinics of North America. 2023 Dec 1
• 21 citations
  Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies.
  Norihiro Watanabe, Feiyan Mo, Rong Zheng, Royce Ma, Vanesa C Bray, Dayenne G van Leeuwen, Juntima Sritabal-Ramirez, Hongxiang Hu, Sha Wang, Birju Mehta, Madhuwanti Sri...> ;Molecular Therapy. 2023 Jan 4
• 2 citations
  Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
  Furqan, F., Ahn, K., Chen, Y., Kaur, M., Abutalib, S., Ahmed, N., Ahmed, S., Kharfan-Dabaja, M., Friedberg, J., Gregory, T., Hill, L., Sterling, C., Barta, S., Shadman...> ;British Journal of Haematology. 2023 Jan 1
• 12 citations
  Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients.
  Spyridoula Vasileiou, LaQuisa Hill, Manik Kuvalekar, Aster G Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, Kimberly Mooney, Natalia Lapteva, Bambi J Gril...> ;Haematologica. 2023 Jul 1
• 8 citations
  Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs.
  David H M Steffin, Ibrahim N Muhsen, LaQuisa C Hill, Carlos A Ramos, Nabil Ahmed, Meenakshi Hegde, Tao Wang, Mengfen Wu, Stephen Gottschalk, Sarah B Whittle, Premal D ...> ;Blood. 2022 Jul 7
• 14 citations
  Donor-derived multiple leukemia antigen-specific T-cell therapy to prevent relapse after transplant in patients with ALL.
  Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Manik Kuvalekar, Ayumi Watanabe, Catherine Robertson, Natalia Lapteva, Wang Tao, Mengfen Wu, Bambi Grilley, George...> ;Blood. 2022 Apr 28
• 1 citations
  Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma.
  Brian D Friend, Ibrahim N Muhsen, Shreeya Patel, LaQuisa C Hill, Premal Lulla, Carlos A Ramos, S Ravi Pingali, Rammurti T Kamble, Tami D John, Baheyeldin Salem, Saleh ...> ;Bone Marrow Transplantation. 2022 Apr 1
• 3 citations
  Beyond CD19 CAR-T cells in lymphoma.
  Wingchi K. Leung, Adanma Ayanambakkam, Helen E. Heslop, La Quisa C. Hill> ;Current Opinion in Immunology. 2022 Feb 1
• 1 citations
  COVID-specific T's may offset therapeutically endangered B's.
  LaQuisa C Hill, Premal D Lulla> ;Blood. 2022 Jan 6
• 2 citations
  Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow Products.
  Brennan Parmelee Streck, Georges Naufal, George Carrum, LaQuisa Hill, Helen E. Heslop, Carlos A. Ramos, Rammurti T. Kamble, Marsha Cohen, Kimberly East, Maria Sena, Pr...> ;Transplantation and Cellular Therapy. 2021 Sep 1
• 13 citations
  Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.
  Samer Al Hadidi, Deepa Dongarwar, Hamisu M. Salihu, Rammurti T. Kamble, Premal Lulla, La Quisa C. Hill, George Carrum, Carlos A. Ramos, Helen E. Heslop, Saad Z. Usmani> ;Leukemia & Lymphoma. 2021 Jul 18
• 32 citations
  Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant.
  Premal Lulla, Swati Naik, Spyridoula Vasileiou, Ifigeneia Tzannou, Ayumi Watanabe, Manik Kuvalekar, Suhasini Lulla, George Carrum, Carlos A. Ramos, Rammurti T. Kamble,...> ;Blood. 2021 May 13
• 6 citations
  CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment Paradigm.
  LaQuisa Hill, Premal Lulla, Helen E. Heslop> ;Advances in Cell and Gene Therapy. 2019 Jul 1
• 19 citations
  The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma.
  Premal Lulla, LaQuisa Hill, Carlos A. Ramos, Helen E. Heslop> ;Clinical Advances in Hematology & Oncology. 2018 May 1
• 73 citations
  New and emerging therapies for acute and chronic graft versus host disease.
  LaQuisa Hill, Amin M. Alousi, Partow Kebriaei, Rohtesh S. Mehta, Katayoun Rezvani, Elizabeth J. Shpall> ;Therapeutic Advances in Hematology. 2018 Jan 1
• Energy balance during backpacking.
  Hill, L. C.,Swain, D. P.,Hill, E. L.> ;Int J Sports Med. 2008 Apr 18
• Join now to see all

Abstracts/Posters

• T Cell Immunity Toward Viral- and Tumor-Antigens Is Preserved in MDS Patients
  LaQuisa C. Hill, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019